IgG Fusion Proteins for Brain Delivery of Biologics via Blood–Brain Barrier Receptor-Mediated Transport
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IgG Fusion Proteins for Brain Delivery of Biologics via Blood–Brain Barrier Receptor-Mediated Transport
Authors
Keywords
-
Journal
Pharmaceutics
Volume 14, Issue 7, Pages 1476
Publisher
MDPI AG
Online
2022-07-18
DOI
10.3390/pharmaceutics14071476
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacological property, mechanism of action and clinical study results of Pabinafusp Alfa (Genetical Recombination) (IZCARGO® I.V. Infusion 10 mg) as the therapeutic for Mucopolysaccharidosis type-II (Hunter syndrome)
- (2022) Ryuji Yamamoto et al. Folia Pharmacologica Japonica
- Transferrin Receptor Binding BBB-Shuttle Facilitates Brain Delivery of Anti-Aβ-Affibodies
- (2022) Rebecca Faresjö et al. PHARMACEUTICAL RESEARCH
- Iduronate-2-sulfatase fused with anti-hTfR antibody, pabinafusp alfa, for MPS-II: A phase 2 trial in Brazil
- (2021) Roberto Giugliani et al. MOLECULAR THERAPY
- Nonclinical safety evaluation of pabinafusp alfa, an anti-human transferrin receptor antibody and iduronate-2-sulfatase fusion protein, for the treatment of neuronopathic mucopolysaccharidosis type II
- (2021) Ryuji Yamamoto et al. Molecular Genetics and Metabolism Reports
- Examination of a blood-brain barrier targeting β-galactosidase-monoclonal antibody fusion protein in a murine model of GM1-gangliosidosis
- (2021) Michael J. Przybilla et al. Molecular Genetics and Metabolism Reports
- Mathematical Models of Blood-Brain Barrier Transport of Monoclonal Antibodies Targeting the Transferrin Receptor and the Insulin Receptor
- (2021) William M. Pardridge et al. Pharmaceuticals
- Kinetics of Blood–Brain Barrier Transport of Monoclonal Antibodies Targeting the Insulin Receptor and the Transferrin Receptor
- (2021) William M. Pardridge Pharmaceuticals
- Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice
- (2020) Julie C. Ullman et al. Science Translational Medicine
- A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II
- (2020) Torayuki Okuyama et al. MOLECULAR THERAPY
- Plasma Pharmacokinetics of High-Affinity Transferrin Receptor Antibody-Erythropoietin Fusion Protein is a Function of Effector Attenuation in Mice
- (2019) Jiahong Sun et al. MOLECULAR PHARMACEUTICS
- Bi-functional IgG-lysosomal enzyme fusion proteins for brain drug delivery
- (2019) Ruben J. Boado et al. Scientific Reports
- Plasma Pharmacokinetics of Valanafusp Alpha, a Human Insulin Receptor Antibody-Iduronidase Fusion Protein, in Patients with Mucopolysaccharidosis Type I
- (2018) William M. Pardridge et al. BIODRUGS
- A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II
- (2018) Hiroyuki Sonoda et al. MOLECULAR THERAPY
- Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial
- (2018) Roberto Giugliani et al. Orphanet Journal of Rare Diseases
- Blood-Brain Barrier Transport, Plasma Pharmacokinetics, and Neuropathology Following Chronic Treatment of the Rhesus Monkey with a Brain Penetrating Humanized Monoclonal Antibody Against the Human Transferrin Receptor
- (2018) William M. Pardridge et al. MOLECULAR PHARMACEUTICS
- A Brain Penetrating Bifunctional Erythropoietin-Transferrin Receptor Antibody Fusion Protein for Alzheimer’s Disease
- (2018) Rudy Chang et al. MOLECULAR PHARMACEUTICS
- Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial
- (2018) Torayuki Okuyama et al. MOLECULAR THERAPY
- Reduction in Brain Heparan Sulfate with Systemic Administration of an IgG Trojan Horse–Sulfamidase Fusion Protein in the Mucopolysaccharidosis Type IIIA Mouse
- (2017) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- Blood–Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer’s Disease
- (2017) Rudy Chang et al. MOLECULAR PHARMACEUTICS
- Brain and Organ Uptake in the Rhesus Monkey in Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody–Iduronidase Fusion Protein
- (2017) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- CSF, blood-brain barrier, and brain drug delivery
- (2016) William M. Pardridge Expert Opinion on Drug Delivery
- Very High Plasma Concentrations of a Monoclonal Antibody against the Human Insulin Receptor Are Produced by Subcutaneous Injection in the Rhesus Monkey
- (2016) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- Insulin Receptor Antibody−α-N-Acetylglucosaminidase Fusion Protein Penetrates the Primate Blood–Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type B Fibroblasts
- (2016) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- Construction of a hybrid β-hexosaminidase subunit capable of forming stable homodimers that hydrolyze GM2 ganglioside in vivo
- (2016) Michael B Tropak et al. Molecular Therapy-Methods & Clinical Development
- Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan
- (2015) Cara M. Weismann et al. HUMAN MOLECULAR GENETICS
- Insulin receptor antibody-iduronate 2-sulfatase fusion protein: Pharmacokinetics, anti-drug antibody, and safety pharmacology in Rhesus monkeys
- (2014) Ruben J. Boado et al. BIOTECHNOLOGY AND BIOENGINEERING
- Insulin Receptor Antibody–Sulfamidase Fusion Protein Penetrates the Primate Blood–Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type A Cells
- (2014) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle
- (2014) Jens Niewoehner et al. NEURON
- Feasibility and Safety of Systemic rAAV9-hNAGLU Delivery for Treating Mucopolysaccharidosis IIIB: Toxicology, Biodistribution, and Immunological Assessments in Primates
- (2014) Darren A. Murrey et al. Human Gene Therapy Clinical Development
- Blood-Brain Barrier Molecular Trojan Horse Enables Imaging of Brain Uptake of Radioiodinated Recombinant Protein in the Rhesus Monkey
- (2013) Ruben J. Boado et al. BIOCONJUGATE CHEMISTRY
- Combination stroke therapy in the mouse with blood–brain barrier penetrating IgG–GDNF and IgG–TNF decoy receptor fusion proteins
- (2013) Rachita K. Sumbria et al. BRAIN RESEARCH
- Quantitative Atlas of Blood–Brain Barrier Transporters, Receptors, and Tight Junction Proteins in Rats and Common Marmoset
- (2013) Yutaro Hoshi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Disaggregation of Amyloid Plaque in Brain of Alzheimer’s Disease Transgenic Mice with Daily Subcutaneous Administration of a Tetravalent Bispecific Antibody That Targets the Transferrin Receptor and the Abeta Amyloid Peptide
- (2013) Rachita K. Sumbria et al. MOLECULAR PHARMACEUTICS
- Pharmacokinetics and Brain Uptake of an IgG-TNF Decoy Receptor Fusion Protein Following Intravenous, Intraperitoneal, and Subcutaneous Administration in Mice
- (2013) Rachita K. Sumbria et al. MOLECULAR PHARMACEUTICS
- Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier
- (2013) J. A. Couch et al. Science Translational Medicine
- Imaging Amyloid Plaque in Alzheimer’s Disease Brain with a Biotinylated Aβ Peptide Radiopharmaceutical Conjugated to an IgG-Avidin Fusion Protein
- (2012) Rachita K. Sumbria et al. BIOCONJUGATE CHEMISTRY
- IgG-Enzyme Fusion Protein: Pharmacokinetics and Anti-Drug Antibody Response in Rhesus Monkeys
- (2012) Ruben J. Boado et al. BIOCONJUGATE CHEMISTRY
- Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor
- (2012) Ruben J. Boado et al. BIOTECHNOLOGY AND BIOENGINEERING
- Brain Protection from Stroke with Intravenous TNFα Decoy Receptor-Trojan Horse Fusion Protein
- (2012) Rachita K Sumbria et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Merits of Combination Cortical, Subcortical, and Cerebellar Injections for the Treatment of Niemann-Pick Disease Type A
- (2012) Jie Bu et al. MOLECULAR THERAPY
- A Monoclonal Antibody-GDNF Fusion Protein Is Not Neuroprotective and Is Associated with Proliferative Pancreatic Lesions in Parkinsonian Monkeys
- (2012) Sachiko Ohshima-Hosoyama et al. PLoS One
- Delivery of a Peptide Radiopharmaceutical to Brain with an IgG-Avidin Fusion Protein
- (2011) Qing-Hui Zhou et al. BIOCONJUGATE CHEMISTRY
- Expression in CHO cells and pharmacokinetics and brain uptake in the Rhesus monkey of an IgG-iduronate-2-sulfatase fusion protein
- (2011) Jeff Zhiqiang Lu et al. BIOTECHNOLOGY AND BIOENGINEERING
- Brain penetrating IgG-erythropoietin fusion protein is neuroprotective following intravenous treatment in Parkinson's disease in the mouse
- (2011) Qing-Hui Zhou et al. BRAIN RESEARCH
- Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
- (2011) Yasuo Uchida et al. JOURNAL OF NEUROCHEMISTRY
- Reversal of Lysosomal Storage in Brain of Adult MPS-I Mice with Intravenous Trojan Horse-Iduronidase Fusion Protein
- (2011) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- Neuroprotection in experimental stroke in the rat with an IgG–erythropoietin fusion protein
- (2010) Ailing Fu et al. BRAIN RESEARCH
- Intravenous treatment of experimental Parkinson's disease in the mouse with an IgG-GDNF fusion protein that penetrates the blood–brain barrier
- (2010) Ailing Fu et al. BRAIN RESEARCH
- Neuroprotection in stroke in the mouse with intravenous erythropoietin–Trojan horse fusion protein
- (2010) Ailing Fu et al. BRAIN RESEARCH
- Monoclonal Antibody-Glial-Derived Neurotrophic Factor Fusion Protein Penetrates the Blood-Brain Barrier in the Mouse
- (2010) Q.-H. Zhou et al. DRUG METABOLISM AND DISPOSITION
- Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein
- (2010) Ruben J. Boado et al. JOURNAL OF BIOTECHNOLOGY
- Drug Targeting of Erythropoietin Across the Primate Blood-Brain Barrier with an IgG Molecular Trojan Horse
- (2010) R. J. Boado et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Re-Engineering Erythropoietin as an IgG Fusion Protein That Penetrates the Blood−Brain Barrier in the Mouse
- (2010) Qing-Hui Zhou et al. MOLECULAR PHARMACEUTICS
- Receptor-Mediated Abeta Amyloid Antibody Targeting to Alzheimer’s Disease Mouse Brain
- (2010) Qing-Hui Zhou et al. MOLECULAR PHARMACEUTICS
- Genetic Engineering of a Bifunctional IgG Fusion Protein with Iduronate-2-Sulfatase
- (2009) Jeff Zhiqiang Lu et al. BIOCONJUGATE CHEMISTRY
- IgG-single chain Fv fusion protein therapeutic for alzheimer's disease: Expression in CHO cells and pharmacokinetics and brain delivery in the rhesus monkey
- (2009) Ruben J. Boado et al. BIOTECHNOLOGY AND BIOENGINEERING
- Immunotherapy, Vascular Pathology, and Microhemorrhages in Transgenic Mice
- (2009) Donna Wilcock et al. CNS & Neurological Disorders-Drug Targets
- Comparison of Blood-Brain Barrier Transport of Glial-Derived Neurotrophic Factor (GDNF) and an IgG-GDNF Fusion Protein in the Rhesus Monkey
- (2009) R. J. Boado et al. DRUG METABOLISM AND DISPOSITION
- A new generation of neurobiological drugs engineered to overcome the challenges of brain drug delivery
- (2009) R.J. Boado DRUG NEWS & PERSPECTIVES
- AGT-181: Expression in CHO cells and pharmacokinetics, safety, and plasma iduronidase enzyme activity in Rhesus monkeys
- (2009) Ruben J. Boado et al. JOURNAL OF BIOTECHNOLOGY
- Genetic engineering of IgG-glucuronidase fusion proteins
- (2009) Ruben J. Boado et al. JOURNAL OF DRUG TARGETING
- Neurodegenerative lysosomal storage disease in European Burmese cats with hexosaminidase β-subunit deficiency
- (2009) Allison M. Bradbury et al. MOLECULAR GENETICS AND METABOLISM
- Pharmacokinetics and Brain Uptake of a Genetically Engineered Bifunctional Fusion Antibody Targeting the Mouse Transferrin Receptor
- (2009) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- Structure and function of the blood–brain barrier
- (2009) N. Joan Abbott et al. NEUROBIOLOGY OF DISEASE
- Pharmacokinetics and Safety in Rhesus Monkeys of a Monoclonal Antibody-GDNF Fusion Protein for Targeted Blood-Brain Barrier Delivery
- (2009) William M. Pardridge et al. PHARMACEUTICAL RESEARCH
- Genetic Engineering, Expression, and Activity of a Chimeric Monoclonal Antibody−Avidin Fusion Protein for Receptor-Mediated Delivery of Biotinylated Drugs in Humans
- (2008) Ruben J. Boado et al. BIOCONJUGATE CHEMISTRY
- Re-Engineering Biopharmaceuticals for Delivery to Brain with Molecular Trojan Horses
- (2008) William M. Pardridge BIOCONJUGATE CHEMISTRY
- Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse
- (2008) Ruben J. Boado et al. BIOTECHNOLOGY AND BIOENGINEERING
- Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes"
- (2008) A. S. De Groot et al. BLOOD
- Effects of Etanercept and Minocycline in a rat model of spinal cord injury
- (2008) Fabien Marchand et al. EUROPEAN JOURNAL OF PAIN
- Depression, comorbidities and the TNF-α system
- (2008) H. Himmerich et al. EUROPEAN PSYCHIATRY
- Sanfilippo syndrome: A mini-review
- (2008) M. J. Valstar et al. JOURNAL OF INHERITED METABOLIC DISEASE
- GDNF fusion protein for targeted-drug delivery across the human blood–brain barrier
- (2007) Ruben J. Boado et al. BIOTECHNOLOGY AND BIOENGINEERING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now